Publications and Presentations

  • 1. Manian KV, Bharathan SP, Maddali M, Srivastava VM, Srivastava A, Shaji RV. Generation of an integration-free iPSC line (CSCRi005-A) from erythroid progenitor cells of a healthy Indian male individual. Stem Cell Res. 2018 Apr 3;29:148-151.
  • 2. Karathedath S, Rajamani BM, Musheer Aalam SM, Abraham A, Varatharajan S, Krishnamurthy P, Mathews V, Shaji RV, Balasubramanian P. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2. PLoS One. 2017 May 15;12(5):e0177227.
  • 3. Sumitha Prameela Bharathana, Krittika Nandy, Dhavapriya Palani, Nancy Beryl Janet A, Kasthuri Natarajan, Biju George, Alok Srivastava, Shaji RV. Generation of an induced pluripotent stem cell line that mimics the disease phenotypes from a patient with Fanconi anemia by conditional complementation. Stem Cell Research Volume 20, April 2017, Pages 54–57.
  • 4. Sumitha Prameela Bharathan, Kannan Vrindavan Manian, Syed Mohammed Musheer Aalam, Dhavapriya Palani, Prashant Ajit Deshpande, Mankuzhy Damodaran Pratheesh, Alok Srivastava, Shaji RV. Systematic evaluation of markers used for the identification of human induced pluripotent stem cells. Biology Open 2017 6: 100-108; doi: 10.1242/bio.022111.
  • 5. Aalam SM, Manian KV, Bharathan SP, Mayuranathan T, Shaji RV. Identification of Stable OCT4+NANOG- State in Somatic Cell Reprogramming. Cell Reprogram. 2016 Nov;18(6):367-368.
  • 6. Pal R, Mariappan I, Shaji RV. Editorial: Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells: Ushering of a New Era in Personalized Cell Therapies. Curr Stem Cell Res Ther. 2016;11(2):97-8.
  • 7. Manian KV, Aalam SM, Bharathan SP, Srivastava A, Shaji RV. Understanding the Molecular Basis of Heterogeneity in Induced Pluripotent Stem Cells. Cellular Reprogramming 2015 Dec;17(6):427-40.